Physician profile
Eddy Gutierrez
NPI 1790042513
$315,305.45
in general payments reported to CMS, 2019-2025
19 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,087 · 2020: $15K · 2021: $14K · 2022: $55K · 2023: $123K · 2024: $84K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $158K · Travel and Lodging: $28K · Consulting Fee: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $5,490 · Education: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $157,900.00 |
| Travel and Lodging | $28,097.07 |
| Consulting Fee | $23,750.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,312.50 |
| Food and Beverage | $5,490.26 |
| Education | $1,030.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $233,168.11 | 2019-2025 | Impella |
| Fisher & Paykel Healthcare INC | $53,705.24 | 2019-2025 | Fisher & Paykel Healthcare |
| Edwards Lifesciences Corporation | $17,146.58 | 2019-2024 | Hemosphere |
| Becton, Dickinson and Company | $6,300.00 | 2024 | |
| Penumbra, INC. | $1,998.42 | 2022-2025 | Red 72, Indigo System |
| Fisher & Paykel Healthcare Limited | $1,250.00 | 2021 | |
| Baxter Healthcare | $1,030.00 | 2025 | Starling System |
| Biomerieux INC | $159.51 | 2019-2021 | |
| Getinge USA Sales, LLC | $110.66 | 2024 | Cardiohelp |
| Fresenius Kabi USA, LLC | $100.00 | 2019 | |
| Livanova USA, INC. | $94.04 | 2023 | Lifesparc |
| Nxstage Medical, INC. | $72.98 | 2020 | |
| Glaxosmithkline, LLC. | $63.08 | 2019-2020 | |
| Genzyme Corporation | $38.67 | 2019-2020 | |
| Pulmonx Corporation | $25.54 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $16.14 | 2024 | Entre Plus, Flexitouch Plus |
| Shionogi INC | $13.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.63 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddy Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.